3 citations,
January 2020 in “Skin appendage disorders” In Spain, dermatologists most commonly prescribe topical minoxidil and oral finasteride for male hair loss, and topical minoxidil and oral contraceptives for female hair loss. The use of oral dutasteride and oral minoxidil has significantly increased over the past three years.
November 2022 in “Journal of Education, Health and Sport” Combination therapy for hair loss can improve results and reduce side effects.
10 citations,
April 2018 in “Actas Dermo-Sifiliográficas” In 2017, Spanish dermatologists most often prescribed minoxidil and finasteride for male hair loss, and minoxidil and oral contraceptives for premenopausal female hair loss.
November 2014 in “British Journal of Dermatology” Male hair loss is mainly due to thinner hair, not less hair.
1 citations,
April 2016 in “The American Journal of the Medical Sciences” The document concludes that doctors should check for frontal fibrosing alopecia in patients with acquired hyperpigmentation and that early treatment is important.
1 citations,
February 2022 in “JAMA Dermatology” Minoxidil and finasteride are FDA-approved treatments for male hair loss, but off-label use of oral minoxidil, dutasteride, and higher doses of finasteride and minoxidil is increasing.
June 2022 in “Journal of The European Academy of Dermatology and Venereology” Microneedling with topical dutasteride improves hair growth in men with hair loss and is safe to use.
69 citations,
August 2008 in “Journal of The European Academy of Dermatology and Venereology” Oral dutasteride and topical pimecrolimus can safely and effectively treat Frontal Fibrosing Alopecia, leading to significant hair regrowth.
October 2023 in “Facial Plastic Surgery” New treatments for common hair loss include medications, regenerative therapies, and laser therapy, but may not work for everyone.
August 2023 in “GLOBAL JOURNAL FOR RESEARCH ANALYSIS” Effective hair loss treatment requires personalized approaches and patient-provider collaboration.
1 citations,
October 2021 in “Journal of The American Academy of Dermatology” The document concludes that treatments for hair loss in transgender and gender-diverse individuals include topical solutions, oral medications, laser therapy, and hair restoration procedures, with progress assessed after 6-12 months.
January 2008 in “프로그램북(구 초록집)” June 2021 in “European Urology” June 2013 in “Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature” January 2009 in “프로그램북(구 초록집)”
May 2016 in “The Journal of Sexual Medicine” 2 citations,
February 2007 in “PubMed” October 2021 in “European urology open science” August 2022 in “Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature” 1 citations,
November 2010 in “Anticancer Research” February 2014 in “Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature” February 2019 in “DOAJ (DOAJ: Directory of Open Access Journals)” 24 citations,
January 2017 in “International Journal of Trichology” 20 citations,
January 2004 in “PubMed” 1 citations,
December 2020 in “The World Journal of Men's Health” March 2023 in “JAAD case reports” September 2017 in “ics.org”
August 2016 in “Journal of Investigative Dermatology”
August 2016 in “Journal of Investigative Dermatology” September 2024 in “Frontiers in Neuroendocrinology” 5-alpha reductase inhibitors may help protect the brain and gut in Parkinson's disease.